Spaulding Clinical Expands Services to Include ADME Clinical Trials

ADME studies are vital components of drug development, providing critical insights into the behavior of drugs within the human body. By measuring the absor...

June 23, 2023 | Friday | News
Challenges and strategies for characterization of next-generation bispecific antibodies

But developing a bispecific antibody presents several challenges, including those related to dual binding, screening, pharmacodynamics, tissue tropism, and...

June 22, 2023 | Thursday | Analysis
Illumina Ventures to Launch Illumina® Ventures Labs

“This expansion of our relationship with Illumina is a continuation of Illumina Ventures’ strategy to pursue earlier stage investing,” sa...

June 21, 2023 | Wednesday | News
Deloitte Launches 'Illustrate Change' Medical Illustration Library

Deloitte is proud to announce the launch of "Illustrate Change," a project that seeks to build momentum around representation in medical illustrations and ...

June 21, 2023 | Wednesday | News
Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with canc...

June 20, 2023 | Tuesday | News
First Patient Dosed in Telix's Phase II STARBURST Study Expanding TLX250-CDx Indication in Australia

The STARBURST study (ClinicalTrials.gov Identifier: NCT05563272) is a prospective, open label Phase II "basket" study to investigate CAIX expression in pat...

June 19, 2023 | Monday | News
QIAGEN provides reminder on settlement mechanics of 2023 and 2024 convertible notes

QIAGEN N.V.  announced  a notice (reiterating its notice to holders dated January 9, 2019) to holders of the following: - 0.500% Senior Unsecure...

June 19, 2023 | Monday | News
PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA to the University of Sydney

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF, a biotechnology company focused on the researc...

June 19, 2023 | Monday | News
Cholesgen Enters Collaboration and Licensing Agreement with AstraZeneca for Hypercholesterolemia

This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...

June 17, 2023 | Saturday | News
Astellas and Cullgen Forge Strategic Collaboration to Advance Targeted Protein Degraders

Under the terms of the agreement, the two companies aim to develop multiple targeted protein degraders by combining Cullgen's proprietary uSMITE™ tar...

June 15, 2023 | Thursday | News
Swiss American CDMO Partners with BioNTX to Launch Biotech Alliance

-Swiss American CDMO and BioNTX have partnered to host the inaugural Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) launch meeting ...

June 15, 2023 | Thursday | News
Future Fields and Jenthera Therapeutics Collaborate on Novel Cancer Biologics Delivery Protein

Future Fields, a pioneering biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protei...

June 14, 2023 | Wednesday | News
Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial1 is being led by Lanhzou Biotechnique Development  wi...

June 13, 2023 | Tuesday | News
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe

SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and supp...

June 13, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close